NextEye Co (137940) Fair Value & Analysis
Industrials · KR · Market cap 15.3B KRW
Fair value as of: Jun 24, 2026
Analysis
NextEye Co (137940) currently trades at 1,532 KRW, while our model-based Fair Value estimate is 1,712 KRW — implying the stock looks roughly 11.7% undervalued today. We read business quality at 90/100 (high quality), in the Industrials sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: low) — always confirm before acting.
About the company
NextEye Co., Ltd. develops and supplies machine vision systems for semiconductor, automotive, mobile phone, and household industries. The company offers FPD glass testing, polarized film testing, BLU detection system, and prism film testing; food container inspection, can joint detection, bottle appearance detection, packing box assembly detection, and date printing detection products. It also provides mobile phones and electronic machines, such as cover case three-dimensional measurement, PCB inspection of machine plate parts, mobile rear assembly's detection, and appearance detection products. In addition, the company offers vision lighting for testing equipment; indoor and outdoor lighting; and industrial and special lighting, and light panels, as well as operates an Internet based purchasing platform. The company was founded in 1998 and is headquartered in Anyang, South Korea.
Open the full interactive analysis →
Similar stocks
Frequently asked questions
Is NextEye Co (137940) undervalued?
What is the fair value of 137940?
What is the quality score of 137940?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.